
    
      Eligibility: Patient(s) must be enrolled in the Discovery Multi-Center Prospective Study. The
      patient must consent to participation in the Discovery Long-term Survivorship Study.

      In order to continue to follow the multi-center subjects long-term Biomet would like to
      extend the follow-up to include annual follow-ups from 10 to 15 years to document long-term
      survivorship. The annual follow-up will be obtained by sending annual questionnaire directly
      to the patients by mail. The Patient ASES questionnaire and survivorship data questions will
      be collected.
    
  